Laurus Labs Limited has informed the Exchange regarding a press release dated May 31, 2023, titled "Laurus Labs further invests in Cell and Gene therapy company ImmunoACT; to hold 33.86% stake post- completion of the transaction".
Laurus Labs Limited has informed the Exchange regarding a press release dated May 31, 2023, titled "Laurus Labs further invests in Cell and Gene therapy company ImmunoACT; to hold 33.86% stake post- completion of the transaction".